Abstract Body

Background: The Johns Hopkins Hospital (JHH) Emergency Department (ED) has served as both an observational window on the HIV-epidemic for over 25 years, and as a pioneer in ED-based testing and linkage to care programs. We document the changing nature of the local epidemic in inner city Baltimore and the success of ED-based strategic approaches to curtail the epidemic.

Methods: We analyzed 7 discrete identity-unlinked serosurveys conducted on 18,240 untargeted adult JHH-ED patients between 1987-2013 for demographic trends in HIV prevalence, cross-sectional incidence estimates, viral load and HCV prevalence. JHH ED HIV testing and linkage to care programs were initiated in 2005 and continue to date.

Results: HIV prevalence in 1987 was 5.2%, peaked at >11% from 1992-2003, and then declined to 5.6% in 2013. While seroprevalence was highest for black males, (initial 10%, peak 20%, last 10%), and lowest for white females, the time trend for prevalence was consistent for all groups. Proportion of undiagnosed HIV declined over time from 77% in 1987, 28% in 1992, and 12% by 2013 (p<0.001). HIV incidence estimates in 2001 were 2.1% and declined steadily to 0.16% by 2013 (p<0.001). Proportion of HIV+ individuals with viral suppression (<400 c/ml) increased steadily from 23% in 2001 to 59% by 2013 (p<0.001). Consistent with increasing viral suppression, 80% of 214 HIV+ individuals surveyed in 2013 had antiretroviral drugs detected in their sera, a marked increase from 2007 (27%) (p<0.001). The trends in improved outlook were consistent in all demographic subgroups. However, HCV in this population remained at 18-19% from 1988 until 2007 and declined only slightly to 14% by 2013. Dual HIV/HCV infection remained relatively stable (48%-52%) from 2007 to 2013.

Conclusions: Over a 25-year period, JHH ED-based HIV testing evolved from describing the local epidemic to playing a major strategic role in locally controlling the epidemic. This is evidenced by declining undiagnosed HIV infection, increased use of ARVs with increasing viral suppression and a consequential decline in incidence among JHH ED patients. While causation is not directly addressed, the improvements in HIV status in this population coincide with JHH ED-based testing, while the linkage to care program is associated with increased ARV therapy. Noting only a comparative slight decrease in HCV infection in the same population underscores the potential for a causal relationship.